wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33727733-504C8EDC-1CBA-4089-8509-DD0E2AF78FDC
Q33727733-504C8EDC-1CBA-4089-8509-DD0E2AF78FDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33727733-504C8EDC-1CBA-4089-8509-DD0E2AF78FDC
Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.
P2860
Q33727733-504C8EDC-1CBA-4089-8509-DD0E2AF78FDC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33727733-504C8EDC-1CBA-4089-8509-DD0E2AF78FDC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1c40a5135453683ba121150f16bdbec59e87537d
P2860
Persistence and adherence with the new beta-3 receptor agonist, mirabegron, versus antimuscarinics in overactive bladder: Early experience in Canada